FDA NDC Directory · JSON-LD · Markdown

Lenalidomide

NDC 69097-604 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA214618
Dosage form / routeCAPSULE · ORAL
Active ingredientsLENALIDOMIDE (2.5 mg/1)
Marketing started20230309
Package count1

External sources

Source: openFDA. Public-domain (CC0).